Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptide
-
- Target See all Parkin (PARK2) products
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Origin
- Human, Cow, Monkey, Pig, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-Parkin Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Synonyms
- CG10523 Peptide, Dmel\\CG10523 Peptide, Dpark Peptide, SD01679 Peptide, dpk Peptide, AR-JP Peptide, LPRS2 Peptide, PDJ Peptide, PRKN Peptide, Park Peptide, Prkn Peptide, si:ch211-123f21.1 Peptide, zgc:112390 Peptide, pdr-1 Peptide, PARK2 Peptide, parkin Peptide, parkin RBR E3 ubiquitin protein ligase Peptide, Parkinson disease (autosomal recessive, juvenile) 2, parkin Peptide, park Peptide, PRKN Peptide, Prkn Peptide, prkn Peptide, CpipJ_CPIJ014867 Peptide, Park2 Peptide
- Background
- PRKN, E3 ubiquitin-protein ligase parkin, Parkinson juvenile disease protein 2, Parkinson disease protein 2
- Gene ID
- 5071, 56816
- UniProt
- O60260, Q9JK66
-